Clinical Trial Update: An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis [Phase 1]

View source ↗

Summary

Phase 1 active-comparator safety study evaluating the combination of APG777 and APG990 for moderate-to-severe atopic dermatitis; the trial is currently ACTIVE_N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• APG777
• APG990

Snippet

Sponsor: Apogee Therapeutics, Inc. | Conditions: Atopic Dermatitis | Phase 1 | Status: ACTIVE_NOT_RECRUITING